HTLV-1

Findings by UMN Researchers Could Help Fight Cancer

December 20, 2018

Interdisciplinary researchers from the Institute for Molecular Virology (IMV) have made a key discovery that could help fight Human T-cell leukemia virus type (HTLV-1).

HTLV-1 is a rare but extremely infectious virus spreading among remote areas of central Australia. The virus produces particles that can then spread to other cells in the body. University of Minnesota researchers, including Louis Mansky, PhD, director of the IMV and professor in the School of Dentistry, and his team, created mutations in HTLV-1’s main structural protein (called Gag) and investigated how these mutants affected the production of HTLV-1 particles.

“By creating these mutants, we found important new insights regarding how the structure of the Gag protein is critically important in making new virus particles,” said Mansky, the lead author of the study.

Read the full story.

Other News

Community vaccine event
COVID-19 has greatly impacted the health of Minnesotans and exacerbated the disparities present in BIPOC and immigrant communities.
study finder on computer
One of our most important roles is improving the health of Minnesotans. Participating in clinical trials is a key way for communities to…
people wearing lifejackets on boat in water
The isolated Suba and Luo communities experience some of the highest maternal and neonatal mortality rates in East Africa.